Skip to main content
Log in

Considerations in Animal-Based Preclinical Safety Testing: The United Kingdom Perspective

  • Published:
Drug information journal : DIJ / Drug Information Association Aims and scope Submit manuscript

Abstract

In the United Kingdom, the Home Office regulates the use of animals for experimental and other scientific purposes. Applicants must satisfy the regulatory authority that the animal use is justified and scientifically sound, and that the specific objectives cannot be realized by methods not requiring the use of living animals, or by protocols and endpoints likely to cause less animal suffering. Once granted, project license authorities remain valid for up to five years. In the context of species selection for preclinical safety testing, applicants must make transparent the principles and practices that will be used to select the most relevant species, and the most appropriate and refined plans of work and protocols.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Aldhous P, Coghlan A, Copley J. Let the people speak. New Scientist 1999;May 22: 26–31.

    Google Scholar 

  2. Mulkeen D, Carter C. When should animals suffer? The Times Higher Education Supplement. May 26, 2000. Survey report available at http://www.mori.com.

    Google Scholar 

  3. European Economic Commission. Directive 86/609/ EEC. The approximation of laws, regulations and administrative provisions of the Member States regarding the protection of animals used for experimental and other scientific purposes. Official J European Community 1986;L358:1–28.

    Google Scholar 

  4. Council of Europe. Council of Europe Convention ET. 123. The European Convention for the protection of vertebrate animals used for experimental and other scientific purposes. Strasbourg, France: Council of Europe: 1986.

    Google Scholar 

  5. Home Office. Guidance on the Operation of the Animals (Scientific Procedures) Act 1986. London, England: The Stationery Office; 2000. ISBN 0 10 556706. Available at http://www.homeoffice.gov.uk/ccpd/aps.htm.

    Google Scholar 

  6. Home Office. Report of the Animal Procedures Committee for 1997. London: The Stationery Office; 1998. Available at http://www.apc.gov.uk.

    Google Scholar 

  7. Home Office. Code of Practice for the Housing and Care of Animals Used in Scientific Procedures. London: The Stationery Office; 1989. ISBN 0 10 210789 0. Available at http://www.homeoffice.gov.uk/ccpd/aps.htm.

    Google Scholar 

  8. Home Office. Code of Practice for the Housing and Care of Animals in Designated Breeding and Supplying Establishments. London: The Stationery Office; 1995. ISBN 0 10 212595 3. Available at http://www.homeoffice.gov.uk/ccpd/aps.htm.

    Google Scholar 

  9. European Economic Commission. Commission Directive 2000/33/EC, adapting to technical progress for the 27th time the Dangerous Substances Directive 67/548/EEC. Official J European Community. June 8, 2000, L136, 90–107.

    Google Scholar 

  10. European Federation of Pharmaceutical Industries Associations. The Pharmaceutical Industry in Figures 2000 Edition. Brussels, Belgium: EFPIA; 2000.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Jon Richmond BSc (Hons.) Med Sci, MB ChB, FRCSEd.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Richmond, J. Considerations in Animal-Based Preclinical Safety Testing: The United Kingdom Perspective. Ther Innov Regul Sci 35, 617–621 (2001). https://doi.org/10.1177/009286150103500234

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1177/009286150103500234

Key Words

Navigation